Gut microbiota in nonalcoholic fatty liver disease: a PREDIMED-Plus trial sub analysis-Reference-Cited by-同舟云学术

Gut microbiota in nonalcoholic fatty liver disease: a PREDIMED-Plus trial sub analysis

Published:2023-06-21 Issue:1 Volume:15 Page:
ISSN:1949-0976
Container-title:Gut Microbes
language:en
Short-container-title:Gut Microbes

Author:

Gómez-Pérez Ana María¹²,Ruiz-Limón Patricia¹²,Salas-Salvadó Jordi²³⁴,Vioque Jesús⁵⁶,Corella Dolores²⁷,Fitó Montse²⁸,Vidal Josep⁹¹⁰,Atzeni Alessandro²³⁴,Torres-Collado Laura⁵⁶,Álvarez-Sala Andrea²⁷,Martínez María Ángeles²³⁴,Goday Albert²⁸,Benaiges David²⁸,García-Gavilán Jesús²³⁴,Bernal López María Rosa²¹¹,Moreno-Indias Isabel¹²^ORCID,Tinahones Francisco J.¹²

Affiliation:

1. Department of Endocrinology and Nutrition, Virgen de la Victoria University Hospital, the Biomedical Research Institute of Malaga and Platform in Nanomedicine (IBIMA-BIONAND Platform), University of Malaga, Malaga, Spain

2. CIBER in Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, Madrid, Spain

3. Department of Biochemistry and Biotechnology, Human Nutrition Unit, University of Rovira I Virgili, Reus, Spain

4. Human Nutrition Unit, Pere I Virgili Health Research Institute (IISPV), Reus, Spain

5. Institute of Health and Biomedical Research of Alicante, University of Miguel Hernández (ISABIAL-UMH), Alicante, Spain

6. CIBER Epidemiology and Public Health (CIBERESP), Carlos III Health Institute, Madrid, Spain

7. Department of Preventive Medicine, University of Valencia, Valencia, Spain

8. Cardiovascular Risk and Nutrition (Regicor Study Group), Hospital Del Mar Research Institute (IMIM), Barcelona, Spain

9. Endocrinology and Nutrition Department, Clinic University Hospital, Barcelona, Spain

10. Endocrinology and Nutrition Department, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain

11. Department of Internal Medicine of Regional University Hospital, Institute of Biomedical Research in Malaga (IBIMA), Málaga, Spain

Funder

Instituto de Salud Carlos III

Implementación y evaluación de una intervención intensiva sobre la actividad física Cohorte PREDIMED-Plus grant

Recercaixa

Generalitat Valenciana

Grant from the Ministry of Science and Innovation/ISCIII

Horizon 2020

Servicio Andaluz de Salud, both cofunded by FEDER funds

Almond Board of California

Publisher

Informa UK Limited

Subject

Infectious Diseases,Microbiology (medical),Gastroenterology,Microbiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/19490976.2023.2223339

Reference45 articles.

1. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

2. Impact of Genetic Polymorphism on Response to Therapy in Non-Alcoholic Fatty Liver Disease

3. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement

4. Gut microbiota and their metabolites in the progression of non-alcoholic fatty liver disease

5. Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Probiotics may be useful for drug-induced liver dysfunction in patients with depression – A secondary analysis of a randomized clinical trial;Clinical Nutrition ESPEN;2024-10

2. The Ambiguous Correlation of Blautia with Obesity: A Systematic Review;Microorganisms;2024-08-26

3. The interplay between diet and the gut microbiome: implications for health and disease;Nature Reviews Microbiology;2024-07-15

4. Characteristics of gut microbiome in patients with pediatric solid tumor;Frontiers in Pediatrics;2024-07-04

5. Gut microbiome and metabolic dysfunction-associated steatotic liver disease: Pathogenic role and potential for therapeutics;Best Practice & Research Clinical Gastroenterology;2024-05